AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability

Core Insights - AngioDynamics, Inc. reported its financial results for the second quarter of fiscal year 2026, which ended on November 30, 2025, highlighting its focus on medical technology aimed at improving vascular health and cancer treatment options [1]. Financial Performance - The company achieved net sales of $... for the second quarter, indicating a pro forma year-over-year growth [1].